Palo Alto Investors

Total investments

33

Average round size

36M

Portfolio companies

22

Rounds per year

0.94

Lead investments

2

Follow on index

0.33

Exits

15

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
AutomotiveBiotechnologyTransportationMobileHealth CareManufacturingMedicalAutonomous VehiclesPharmaceuticalTherapeutics

Summary

Palo Alto Investors is the famous Corporate Investor, which was founded in 1989. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Palo Alto.

The current fund was established by Will Edwards. Besides them, we counted 3 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Palo Alto Investors, startups are often financed by Vivo Capital, BioAdvance, Venrock. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Third Point Ventures, Technology Partners. In the next rounds fund is usually obtained by Kleiner Perkins, Vivo Capital, Mobius Venture Capital.

The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. Comparing to the other companies, this Palo Alto Investors performs on 17 percentage points more the average number of lead investments. The important activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Semiconductor, Biotechnology. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Deem, NewLeaf Symbiotics, SkyPilot Networks.

Show more

Investments analytics

Analytics

Total investments
33
Lead investments
2
Exits
15
Rounds per year
0.94
Follow on index
0.33
Investments by industry
  • Biotechnology (19)
  • Health Care (17)
  • Therapeutics (11)
  • Pharmaceutical (10)
  • Medical (8)
  • Show 27 more
Investments by region
  • United States (33)
Peak activity year
2005
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
78M
Group Appearance index
0.97
Avg. company exit year
11
Avg. multiplicator
0.86
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Fisker Automotive 14 Jan 2008 Automotive, Transportation, Mobile, Manufacturing, Autonomous Vehicles, Electric Vehicle Early Stage Venture 20M United States, California, Torrance
Garment IO 26 Feb 2020 Software, Manufacturing, Internet of Things Seed 450K United States, Texas, Egypt
NewLeaf Symbiotics 15 Sep 2014 Biotechnology, Sustainability, Agriculture Early Stage Venture 17M United States, Missouri, City of Saint Louis

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.